The phenotypic stability of altered hepatic foci: effects of withdrawal and subsequent readministration of phenobarbital.

ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.

A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

[Anonymous].  1987.  A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.. Carcinogenesis. 8(10):1491-9.

Soft tissue sarcoma: preoperative and postoperative imaging for staging.

Dietary effects on initiation and promotion of hepatocarcinogenesis in rat.

EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.

Vitamin C, vitamin E and cancer (review).

A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat.

Radiofrequency ablation for unresectable tumors of the liver.

Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer.